Literature DB >> 12428765

The neurobiology of apolipoproteins in psychiatric disorders.

J Gregor Sutcliffe1, Elizabeth A Thomas.   

Abstract

A genetic contribution to the transmission of psychiatric disorders has been established and it is now accepted that several genes confer susceptibility to schizophrenia, and similar disorders, giving rise to a complex polygenic mode of inheritance. With the high-throughput molecular profiling techniques available, apolipoproteins have emerged as being important factors in psychiatric disorders. This review will focus on three apolipoproteins that have recently been shown to be elevated in neuropsychiatric disorders: apoD, apoE, and apoL. Furthermore, the authors discuss the role of apoD in the pathology and pharmacotherapy of schizophrenia and bipolar disorder.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12428765     DOI： 10.1385/mn:26:2-3:369

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN： 0893-7648            Impact factor:   5.590


  111 in total

1.  TOGA: an automated parsing technology for analyzing expression of nearly all genes.

Authors:  J G Sutcliffe; P E Foye; M G Erlander; B S Hilbush; L J Bodzin; J T Durham; K W Hasel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Apolipoprotein D interacts with the long-form leptin receptor: a hypothalamic function in the control of energy homeostasis.

Authors:  Z Liu; G Q Chang; S F Leibowitz
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

3.  Altered apolipoprotein D expression in the brain of patients with Alzheimer disease.

Authors:  B Belloir; E Kövari; M Surini-Demiri; A Savioz
Journal:  J Neurosci Res       Date:  2001-04-01       Impact factor: 4.164

4.  Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia.

Authors:  M Rietschel; H Krauss; D J Müller; M M Nöthen; F Macciardi
Journal:  Lancet       Date:  1997 Dec 20-27       Impact factor: 79.321

5.  A specific progesterone-binding component of human breast cyst fluid.

Authors:  W H Pearlman; J L Guériguian; M E Sawyer
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

6.  Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study.

Authors:  B Crespo-Facorro; J Kim; N C Andreasen; D S O'Leary; V Magnotta
Journal:  Biol Psychiatry       Date:  2000-07-15       Impact factor: 13.382

7.  Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene.

Authors:  P N Duchateau; C R Pullinger; M H Cho; C Eng; J P Kane
Journal:  J Lipid Res       Date:  2001-04       Impact factor: 5.922

Review 8.  An overview of reverse cholesterol transport.

Authors:  A R Tall
Journal:  Eur Heart J       Date:  1998-02       Impact factor: 29.983

9.  Apolipoprotein E regulatory region genotype in schizophrenia.

Authors:  T Shinkai; O Ohmori; H Kojima; T Terao; T Suzuki; K Abe; J Nakamura
Journal:  Neurosci Lett       Date:  1998-10-30       Impact factor: 3.046

10.  Frontotemporal cerebral blood flow change during executive and declarative memory tasks in schizophrenia: a positron emission tomography study.

Authors:  J D Ragland; R C Gur; D C Glahn; D M Censits; R J Smith; M G Lazarev; A Alavi; R E Gur
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295
View more
  15 in total

1.  Gene expression profiles in peripheral blood mononuclear cells correlate with salience network activity in chronic visceral pain: A pilot study.

Authors:  A Gupta; S Cole; J S Labus; S Joshi; T J Nguyen; L A Kilpatrick; K Tillisch; B D Naliboff; L Chang; E A Mayer
Journal:  Neurogastroenterol Motil       Date:  2017-02-12       Impact factor: 3.598

2.  Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila.

Authors:  Julien Muffat; David W Walker; Seymour Benzer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

Review 3.  APOL1 Kidney Disease Risk Variants: An Evolving Landscape.

Authors:  Patrick D Dummer; Sophie Limou; Avi Z Rosenberg; Jurgen Heymann; George Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

4.  Apolipoprotein E polymorphism is associated with age of onset in schizophrenia.

Authors:  Olli Kampman; Sami Anttila; Ari Illi; Kari M Mattila; Riikka Rontu; Esa Leinonen; Terho Lehtimäki
Journal:  J Hum Genet       Date:  2004-06-18       Impact factor: 3.172

Review 5.  Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.

Authors:  Chien-An A Hu; Edward I Klopfer; Patricio E Ray
Journal:  FEBS Lett       Date:  2012-03-08       Impact factor: 4.124

6.  High ApoD protein level in the round ligament fat depot of severely obese women is associated with an improved inflammatory profile.

Authors:  Frederik Desmarais; Karl-F Bergeron; Michel Lacaille; Isabelle Lemieux; Jean Bergeron; Simon Biron; Eric Rassart; Denis R Joanisse; Pascale Mauriege; Catherine Mounier
Journal:  Endocrine       Date:  2018-06-04       Impact factor: 3.633

7.  Psychoses and creativity: is the missing link a biological mechanism related to phospholipids turnover?

Authors:  Bradley S Folley; Mikisha L Doop; Sohee Park
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-12       Impact factor: 4.006

Review 8.  Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain.

Authors:  Sarah Dassati; Andreas Waldner; Rüdiger Schweigreiter
Journal:  Neurobiol Aging       Date:  2014-02-05       Impact factor: 4.673

9.  A comparative genomic study in schizophrenic and in bipolar disorder patients, based on microarray expression profiling meta-analysis.

Authors:  Marianthi Logotheti; Olga Papadodima; Nikolaos Venizelos; Aristotelis Chatziioannou; Fragiskos Kolisis
Journal:  ScientificWorldJournal       Date:  2013-03-10

10.  Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood.

Authors:  Chia-Hsiang Chen
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.